High blood pressure pill cuts risk of Parkinson's disease

Feb 06, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of Neurology.

The study involved 7,374 men and women over age 40. Half of the group had Parkinson’s disease; the other half did not have Parkinson’s disease. Among both groups, nearly half used high blood pressure medications, such as calcium channel blockers, ACE inhibitors, AT II antagonists and beta blockers.

The study found people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinson’s disease by 23 percent compared to people who didn’t take the drugs. There was no such effect among people taking ACE inhibitors, AT II antagonists and beta blockers.

“Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinson’s disease while no such association was seen for other high blood pressure medicines,” said study author Christoph R. Meier, PhD, MSc, with University Hospital Basel in Switzerland.

Meier says more research is needed to determine why calcium channel blockers appear to protect against Parkinson’s disease, whether this is indeed a causal association, and why the other high blood pressure medications do not offer a reduced risk.

Source: American Academy of Neurology

Explore further: Student seeks to improve pneumonia vaccines

add to favorites email to friend print save as pdf

Related Stories

Scientists identify a key to body's use of free calcium

Jan 23, 2014

Scientists at Johns Hopkins report they have figured out a key step in how "free" calcium—the kind not contained in bones—is managed in the body, a finding that could aid in the development of new treatments for a variety ...

Recommended for you

Student seeks to improve pneumonia vaccines

18 hours ago

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

20 hours ago

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

Better living through mitochondrial derived vesicles

Aug 19, 2014

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

Aug 19, 2014

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

User comments : 0